Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier

Omid Veiseh, Conroy Sun, Chen Fang, Narayan Bhattarai, Jonathan Gunn, Forrest M Kievit, Kim Du, Barbara Pullar, Donghoon Lee, Richard G. Ellenbogen, Jim Olson, Miqin Zhang

Research output: Contribution to journalArticle

263 Citations (Scopus)

Abstract

Nanoparticle-based platforms have drawn considerable attention for their potential effect on oncology and other biomedical fields. However, their in vivo application is challenged by insufficient accumulation and retention within tumors due to limited specificity to the target, and an inability to traverse biological barriers. Here, we present a nanoprobe that shows an ability to cross the blood-brain barrier and specifically target brain tumors in a genetically engineered mouse model, as established through in vivo magnetic resonance and biophotonic imaging, and histologic and biodistribution analyses. The nanoprobe is comprised of an iron oxide nanoparticle coated with biocompatible polyethylene glycol-grafted chitosan copolymer, to which a tumor-targeting agent, chlorotoxin, and a near-IR fluorophore are conjugated. The nanoprobe shows an innocuous toxicity profile and sustained retention in tumors. With the versatile affinity of the targeting ligand and the flexible conjugation chemistry for alternative diagnostic and therapeutic agents, this nanoparticle platform can be potentially used for the diagnosis and treatment of a variety of tumor types.

Original languageEnglish (US)
Pages (from-to)6200-6207
Number of pages8
JournalCancer Research
Volume69
Issue number15
DOIs
StatePublished - Aug 1 2009

Fingerprint

Blood-Brain Barrier
Brain Neoplasms
Magnetic Resonance Imaging
Nanoparticles
Neoplasms
Ligands
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. / Veiseh, Omid; Sun, Conroy; Fang, Chen; Bhattarai, Narayan; Gunn, Jonathan; Kievit, Forrest M; Du, Kim; Pullar, Barbara; Lee, Donghoon; Ellenbogen, Richard G.; Olson, Jim; Zhang, Miqin.

In: Cancer Research, Vol. 69, No. 15, 01.08.2009, p. 6200-6207.

Research output: Contribution to journalArticle

Veiseh, O, Sun, C, Fang, C, Bhattarai, N, Gunn, J, Kievit, FM, Du, K, Pullar, B, Lee, D, Ellenbogen, RG, Olson, J & Zhang, M 2009, 'Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier', Cancer Research, vol. 69, no. 15, pp. 6200-6207. https://doi.org/10.1158/0008-5472.CAN-09-1157
Veiseh, Omid ; Sun, Conroy ; Fang, Chen ; Bhattarai, Narayan ; Gunn, Jonathan ; Kievit, Forrest M ; Du, Kim ; Pullar, Barbara ; Lee, Donghoon ; Ellenbogen, Richard G. ; Olson, Jim ; Zhang, Miqin. / Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. In: Cancer Research. 2009 ; Vol. 69, No. 15. pp. 6200-6207.
@article{49c73a55035b4d7b8606ae4016ebd86e,
title = "Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier",
abstract = "Nanoparticle-based platforms have drawn considerable attention for their potential effect on oncology and other biomedical fields. However, their in vivo application is challenged by insufficient accumulation and retention within tumors due to limited specificity to the target, and an inability to traverse biological barriers. Here, we present a nanoprobe that shows an ability to cross the blood-brain barrier and specifically target brain tumors in a genetically engineered mouse model, as established through in vivo magnetic resonance and biophotonic imaging, and histologic and biodistribution analyses. The nanoprobe is comprised of an iron oxide nanoparticle coated with biocompatible polyethylene glycol-grafted chitosan copolymer, to which a tumor-targeting agent, chlorotoxin, and a near-IR fluorophore are conjugated. The nanoprobe shows an innocuous toxicity profile and sustained retention in tumors. With the versatile affinity of the targeting ligand and the flexible conjugation chemistry for alternative diagnostic and therapeutic agents, this nanoparticle platform can be potentially used for the diagnosis and treatment of a variety of tumor types.",
author = "Omid Veiseh and Conroy Sun and Chen Fang and Narayan Bhattarai and Jonathan Gunn and Kievit, {Forrest M} and Kim Du and Barbara Pullar and Donghoon Lee and Ellenbogen, {Richard G.} and Jim Olson and Miqin Zhang",
year = "2009",
month = "8",
day = "1",
doi = "10.1158/0008-5472.CAN-09-1157",
language = "English (US)",
volume = "69",
pages = "6200--6207",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "15",

}

TY - JOUR

T1 - Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier

AU - Veiseh, Omid

AU - Sun, Conroy

AU - Fang, Chen

AU - Bhattarai, Narayan

AU - Gunn, Jonathan

AU - Kievit, Forrest M

AU - Du, Kim

AU - Pullar, Barbara

AU - Lee, Donghoon

AU - Ellenbogen, Richard G.

AU - Olson, Jim

AU - Zhang, Miqin

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Nanoparticle-based platforms have drawn considerable attention for their potential effect on oncology and other biomedical fields. However, their in vivo application is challenged by insufficient accumulation and retention within tumors due to limited specificity to the target, and an inability to traverse biological barriers. Here, we present a nanoprobe that shows an ability to cross the blood-brain barrier and specifically target brain tumors in a genetically engineered mouse model, as established through in vivo magnetic resonance and biophotonic imaging, and histologic and biodistribution analyses. The nanoprobe is comprised of an iron oxide nanoparticle coated with biocompatible polyethylene glycol-grafted chitosan copolymer, to which a tumor-targeting agent, chlorotoxin, and a near-IR fluorophore are conjugated. The nanoprobe shows an innocuous toxicity profile and sustained retention in tumors. With the versatile affinity of the targeting ligand and the flexible conjugation chemistry for alternative diagnostic and therapeutic agents, this nanoparticle platform can be potentially used for the diagnosis and treatment of a variety of tumor types.

AB - Nanoparticle-based platforms have drawn considerable attention for their potential effect on oncology and other biomedical fields. However, their in vivo application is challenged by insufficient accumulation and retention within tumors due to limited specificity to the target, and an inability to traverse biological barriers. Here, we present a nanoprobe that shows an ability to cross the blood-brain barrier and specifically target brain tumors in a genetically engineered mouse model, as established through in vivo magnetic resonance and biophotonic imaging, and histologic and biodistribution analyses. The nanoprobe is comprised of an iron oxide nanoparticle coated with biocompatible polyethylene glycol-grafted chitosan copolymer, to which a tumor-targeting agent, chlorotoxin, and a near-IR fluorophore are conjugated. The nanoprobe shows an innocuous toxicity profile and sustained retention in tumors. With the versatile affinity of the targeting ligand and the flexible conjugation chemistry for alternative diagnostic and therapeutic agents, this nanoparticle platform can be potentially used for the diagnosis and treatment of a variety of tumor types.

UR - http://www.scopus.com/inward/record.url?scp=68049144958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68049144958&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-09-1157

DO - 10.1158/0008-5472.CAN-09-1157

M3 - Article

VL - 69

SP - 6200

EP - 6207

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 15

ER -